Introducing LUBRITAB RBW (Rice Bran Wax)

Published: 14-Nov-2022 Featured companies: JRS Pharma
Ingredients

The clean label lubricant for tablet and capsule formulations

LUBRITAB RBW (Rice Bran Wax) is the innovative all-natural lubricant designed to meet growing clean label demands. Developed from rice, this plant-based ingredient is vegan, gluten-free, and offers a sustainable solution for tablet and capsule formulation.

LUBRITAB RBW Regulatory status currently only for use in USA Nutra products.

Benefits of Using LUBRITAB RBW Rice Bran Wax

LUBRITAB RBW has multiple advantages for nutraceutical formulations:

  • The only clean label lubricant
  • Sustainably sourced
  • Comparable use level to Standard lubricants
  • Robust tablets Low Risk of overblending
  • Minimal impact of tablet disintegration
  • Inert for improved API stability

Packaging Available in 25 kg drums or 5 kg pails

Download the brochure

Featured companies

JRS Pharma is a leading manufacturer of excipients, offering a complete portfolio of excipient solutions for the pharmaceutical and nutraceutical industries. Our excipients...
See more

You may also like

Manufacturing

Ti02-free coating platform for EU tablet producers

Read more
Vivacoat free has been launched to help manufacturers formulate products without titanium dioxide

Trending Articles

  1. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  2. Causes and solutions for dark spots in tablet manufacturing Natoli Engineering examines the causes and solutions for dark spots that can halt production
  3. The evolution of the pharma industry: From reactive to disruptive Globally, the pharma industry has witnessed waves of changes during the last century; we have evolved, writes Ajit Kanetkar, Head, Process Technology, ACG, from maintaining a conservative outlook and being solely reactive to disease and healthcare issues to having a radical and disruptive approach
  4. Highly potent APIs: Hazards in classification and handling This variability and subjective nature of classification means that the OEL is best considered as a tool for site risk management teams
  5. Small molecules: big market opportunities The rapid rise of biologic drugs in recent years has been accompanied by a market narrative that suggests that innovation and new treatments will be fuelled by breakthroughs in this area, leading to a decline in the small molecule pipeline. This is far from true, notes Kevin Cook, Chief Executive Officer at Sterling Pharma Solutions; both are increasing and small molecule drugs continue to be a mainstay of many drug development portfolios

Relevant companies

See more

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

You may also like

Manufacturing

Ti02-free coating platform for EU tablet producers

Vivacoat free has been launched to help manufacturers formulate products without titanium dioxide
Ingredients

JRS Pharma taps into Chinese market with cDMF filings for excipients portfolio

Ingredients by the German excipient maker have been included in the Chinese Drug Master File with the National Medical Products Administration
Ingredients

JRS PHARMA expands its product portfolio with the addition of the Povidone Family

JRS PHARMA, a leading manufacturer of excipients has announced the worldwide release of the Povidone Family product line, the latest addition to its portfolio
Ingredients

JRS Pharma to offer povidone products

Strategic alliance expands company's product portfolio
Manufacturing

JRS Pharma joins forces with Celonic

Deal will enable JRS to provide biopharma services to health science
Ingredients

JRS Pharma to exhibit at Interphex and ExcipientFest Americas

Will be showcasing its extensive portfolio of excipient products including its latest innovation, PROSOLV EASYtab
Ingredients

Increase tableting efficiency with PROSOLV SMCC

A high functionality tablet binder-diluent can offer far greater compatibility, low strain-rate sensitivity, better flow, less lubricant sensitivity and more densification and consolidation than conventional tableting ingredients
Subscribe now